Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Garlique CardioAssist

This article was originally published in The Tan Sheet

Executive Summary

Chattem will launch new dietary formula "with an advanced heart formula to help reduce the risk of heart disease" in January 2006, the company announces Oct. 11. Garlique CardioAssist is intended for consumers with a moderate risk of developing heart disease and contains plant sterols, niacin, folic act and vitamins B6 and B12 "to help lower total and LDL cholesterol while maintaining health levels of HDL cholesterol," Chattem states. The product is expected to bring in fiscal year 2006 revenues of $3 mil. to $5 mil., the firm adds. NewBullFrog Mosquito Coast also is launching tooffer consumers 8 hours of mosquito repellency as well as SPF 30 protection. The product begins shipping in November to warmer regions such as Florida and Texas. Mosquito Coast will be packaged as a "convenient '2-in-1' fast drying spray" and carries a SRP of $8.99 for 4.7 oz. Chattem first announced the impending launch in a September third-quarter analyst call (1"The Tan Sheet" Sept. 26, 2005, p. 8)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel